Implemented a third-party allocation of new shares.


Tokyo, May. 31, 2018

 

 

Noile-immune Biotech announces Implementing financing on May 31, 2018 by a third-party allocation of new shares to DCI Partners Co., Ltd., The Saikyo Bank, Ltd., BiGEN Co., Ltd. and Sosei Rmf1. With this funding Noile-immune will not only strengthen the foundation of management base, but also accelerate R&D.